Synapse - Ferrata Storti Foundation

Results (357)

The promised land

Editorial

Stein, E. M.
Haematologica (2021)

The post-hematopoietic cell transplantation microbiome: Relationships with transplant outcome and potential therapeutic targets

Review

van Lier, Y. F.; van den Brink, M. R. M.; Hazenberg, M. D.; Markey, K. A.
Haematologica (2021)

Fulltext@MSK | Save

Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in human immunodeficiency virus-associated, B-cell non-Hodgkin lymphoma

Journal Article

Sparano, J. A.; Lee, J. Y.; Kaplan, L. D.; Ramos, J. C.; Ambinder, R. F.; Wachsman, W.; Aboulafia, D.; Noy, A.; Henry, D. H.; Ratner, L.; more...
Haematologica (2021)

Fulltext@MSK | Save

Myeloid/lymphoid neoplasms with eosinophilia/basophilia and ETV6-ABL1 fusion: Cell-of-origin and response to tyrosine kinase inhibition

Research Letter

Yao, J.; Xu, L.; Aypar, U.; Meyerson, H. J.; Londono, D.; Gao, Q.; Baik, J.; Dietz, J.; Benayed, R.; Sigler, A.; more...
Haematologica (2021)

Fulltext@MSK | Save

Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma

Research Letter

Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
Haematologica (2021)

Fulltext@MSK | Save

Severe delayed hemolytic transfusion reaction due to anti-Fy3 in a patient with sickle cell disease undergoing red cell exchange prior to hematopoietic progenitor cell collection for gene therapy

Journal Article

Stone, E. F.; Avecilla, S. T.; Wuest, D. L.; Lomas-Francis, C.; Westhoff, C. M.; Diuguid, D. L.; Sadelain, M.; Boulad, F.; Shi, P. A.
Haematologica (2021)

Fulltext@MSK | Save

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia

Research Letter

Eyre, T. A.; Lamanna, N.; Roeker, L. E.; Ujjani, C. S.; Hill, B. T.; Barr, P. M.; Lansigan, E.; Cheson, B. D.; Yazdy, M.; Allan, J. N.; more...
Haematologica (2021)

Fulltext@MSK | Save

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia